Lv11
20 积分 2022-07-07 加入
Abstract 2890: IMGN151 - A next generation folate receptor alpha targeting antibody drug conjugate active against tumors with low, medium and high receptor expression
2小时前
已完结
Preclinical evaluation and pilot clinical study of [68Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging
18天前
已完结
Preclinical screening of anti‐HER2 nanobodies for molecular imaging of breast cancer
18天前
已完结
Development of a 99mTc-Labeled Single-Domain Antibody for SPECT/CT Assessment of HER2 Expression in Breast Cancer
18天前
已完结
Noninvasive Imaging of Tumor PD-L1 Expression Using [99mTc]Tc-Labeled KN035 with SPECT/CT
18天前
已完结
Surface-Induced Protein Aggregation and Particle Formation in Biologics: Current Understanding of Mechanisms, Detection and Mitigation Strategies
2个月前
已完结
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial
3个月前
已完结
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin
3个月前
已关闭
Recognition of Mesothelin by the Therapeutic Antibody MORAb-009
3个月前
已完结
The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model
3个月前
已完结
皖公网安备34019202002308
